Evaluation of point of care cd4 testing in ethiopia
This presentation is the property of its rightful owner.
Sponsored Links
1 / 29

Evaluation of point of care CD4 Testing in Ethiopia PowerPoint PPT Presentation


  • 277 Views
  • Uploaded on
  • Presentation posted in: General

Evaluation of point of care CD4 Testing in Ethiopia. Belete Tegbaru National HIV Laboratory The Ethiopian Health and Nutrition Research Institute Addis Ababa, Ethiopia. 6 th IAS Conference July 17-20, Rome Italy. Presentation outline. Background Problems & questions Objective

Download Presentation

Evaluation of point of care CD4 Testing in Ethiopia

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Evaluation of point of care cd4 testing in ethiopia

Evaluation of point of care CD4 Testing in Ethiopia

Belete Tegbaru

National HIV Laboratory

The Ethiopian Health and Nutrition Research Institute

Addis Ababa, Ethiopia

6th IAS Conference

July 17-20, Rome Italy


Presentation outline

Presentation outline

  • Background

  • Problems & questions

  • Objective

  • Plan of the evaluation

  • Methodology

  • Results

  • Summary

  • Expected Benefits of POC instruments

  • Anticipated Challenges for implementation


Evaluation of point of care cd4 testing in ethiopia

As of end of March 2011

In Ethiopia (80 Million Population):

233,361

HIV testing sites

2,309

6,592,896

[+ve, 80,318 (1.2%)]

Total Tested (2010/11)

  • 698

    • 108 Hospitals

    • 590 HCs

Sites giving ART

Sites giving CD4 testing service

  • 138

    • All Hospitals

Currently on ART


Problems questions

Problems & questions

  • Absence of on time CD4 count results (centralized and referred)

Service

  • Distance to sites

  • TAT for results, HIV-DR?

Lost follow-up

  • transport ,storage & power interruption

Cold chain system

Cost

Expertise, maintenance, training, referral linkage


Objective

Objective

To evaluate a point-of-care technology (PIMATM) at different level for CD4 testing sites

  • PimaTM CD4 + T cell Technology - against standard CD4 instruments

  • To see the feasibility: of PIMA for CD4 testing

  • To see how far PimaTMCD4 + T cell Technology could help the facilities to reach their patients on time


Evaluation of point of care cd4 testing in ethiopia

Handy & can be charged for those without electricity

Reagent at room temperature

Can be done from finger prick


Plan of the evaluation

Plan of the evaluation

With standard Machines at central &

Hospital lab (N=2 sites, 300 samples)

Phase-I

At Health center level; referred samples (n=7 sites, 750 samples)

+ Finger prick samples (300 samples)

Phase-II

Finger Prick samples

(n=10 sites, 500 samples)

Phase-III


Methodology

Methodology

  • Evaluate against standard machines (FACSCalibur and FACSCount)

  • Intra-test, inter-test, inter-instrument, interpersonal variations were determined

  • Referred samples for FACSCount to referral sites and PIMA on site results were compared

  • Operational parameters (failure rate, rate of additional devices for planning and training were evaluated)


Results

Results

Lab: 27(8.1%, 5.4-11.1)

Site level: 17(10.7%,7.2-18.7] for planning

9.4% extra devices


Evaluation of point of care cd4 testing in ethiopia

PIMA versus

FACSCalibur

FACSCount


Evaluation of point of care cd4 testing in ethiopia

Closeness of values


Evaluation of point of care cd4 testing in ethiopia

PIMA versus FACSCount

at health centers before and after referral


Evaluation of point of care cd4 testing in ethiopia

PIMA Misclassification rate

Taking 200 cells/µl as a cutoff


Variability studies

Variability studies


Evaluation of point of care cd4 testing in ethiopia

Sample

<200: 103 cells/µl

>200: 510 cells/µl

Each test= 10x

Vial-B

Vial-A

Day-1

TECH-B

TECH-A

TECH-A

PIMA-1

PIMA-2

PIMA-1

PIMA-1

Day-2

TECH-A

TECH-A


Evaluation of point of care cd4 testing in ethiopia

Sample

Vial-B

Vial-A

Day-1

TECH-B

TECH-A

TECH-A

PIMA-1

PIMA-2

PIMA-1

PIMA-1

Inter machine variation


Evaluation of point of care cd4 testing in ethiopia

Sample

Vial-B

Vial-A

Day-1

TECH-B

TECH-A

TECH-A

PIMA-1

PIMA-2

PIMA-1

PIMA-1

Inter technician variation


Evaluation of point of care cd4 testing in ethiopia

Sample

Vial-B

Vial-A

Day-1

TECH-B

TECH-A

TECH-A

PIMA-1

PIMA-1

Inter-assay variation


Evaluation of point of care cd4 testing in ethiopia

Sample

Vial-B

Vial-A

Day-1

TECH-B

TECH-A

TECH-A

PIMA-1

PIMA-1

Intra-assay variation


Evaluation of point of care cd4 testing in ethiopia

Sample

Vial-B

Vial-A

Day-1

TECH-B

TECH-A

TECH-A

PIMA-1

PIMA-2

PIMA-1

PIMA-1

PIMA-1

PIMA-1

Day-2: Daily variation


Meaning of pont of care

Meaning of Pont-of-care

  • In phase-II: 4 HCs tested 255 patients by both PIMA and FACSCount

**- drawing of blood for 2nd time due to lost results

* Reading failure


Expected benefits of poc instruments

Expected Benefits of POC instruments


Evaluation of point of care cd4 testing in ethiopia

  • Expansion of sites

  • Reduce the cost of referral

  • Reduce the cost of cold chain

  • Serve the patient on site

  • Reduce lost follow-up

Program

  • Limited training required

  • Storage (room temp. and space)

  • Sample collection (easy and safe)

  • Can be done at lower level

Laboratory

  • Get service on site

  • Initiate ART on time

  • No cost for transport & others

  • Follow their status at any time

  • Increase quality of life

Patient


Anticipated challenges for implementation

Anticipated Challenges for implementation

  • Supply of reagents and machines Vs expansion

    • Mechanism to solve – connectivity and planning

  • Maintenance Vs expansion

    • Preventive maintenance free-

    • Technical service replacement strategy

  • CD4% for pediatric cases

    • development


Summary

Summary

  • Good agreement with standard machines with low bias and good percentage of similarity

  • On Planning: a total of 9.4% extra devices required at lab & site level

  • Failure rate on testing= 8/306= 2.6% at lab level

  • Gives extra advantage – No need to re-draw blood -point-of-care ~5% of the cases

  • Power interruption was not a problem at site level

  • The intra-, inter-tests are within WHO recommendations for ≤200 and >200 cells/l CD4 Tests


Collaborating individuals

Collaborating Individuals

  • Dr. TsehayneshMeseleEHNRI

  • Dr. Almaz AbebeEHNRI

  • Mr. Dereje TeshomeEHNRI

  • Mr. ErmiasHailuEHNRI

  • Mr. FeyissaChallaEHNRI

  • MrHabteyesHailuEHNRI

  • Mrs. Yodit AlemayehuEHNRI

  • Katherine Theiss-Nyland CHAI

  • Dr. Peter TrevorCHAI


Evaluation of point of care cd4 testing in ethiopia

Ethiopian Health and Nutrition Research Institute –Organize and lead the evaluation

CHAI: Financial, material and technical support

Alere: Training of laboratory personnel at the National HIV laboratory


Evaluation of point of care cd4 testing in ethiopia

THANK YOU!


  • Login